Confirmed cases of RR-/MDR-TB in Botswana
Botswana: Confirmed cases of RR-/MDR-TB was 36 in 2024. ▼ Falling
Confirmed cases of RR-/MDR-TB in Botswana, 2007–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for confirmed cases of rr-/mdr-tb in Botswana is 36, measured in 2024.
The figure is down 35.7% on the previous year and down 12.2% over ten years.
Over the whole period, confirmed cases of rr-/mdr-tb in Botswana peaked at 139 in 2007 and was at its lowest, 15, in 2021.
Botswana ranks 101st of 195 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 17 years of available data.
Confirmed cases of RR-/MDR-TB in Botswana, year by year
| Year | Value | Change |
|---|---|---|
| 2007 | 139 | — |
| 2008 | 126 | -9.4% |
| 2009 | 139 | +10.3% |
| 2010 | 122 | -12.2% |
| 2011 | 54 | -55.7% |
| 2012 | 71 | +31.5% |
| 2013 | 67 | -5.6% |
| 2014 | 41 | -38.8% |
| 2015 | 57 | +39.0% |
| 2016 | 104 | +82.5% |
| 2017 | 87 | -16.3% |
| 2018 | 86 | -1.1% |
| 2019 | 53 | -38.4% |
| 2020 | 65 | +22.6% |
| 2021 | 15 | -76.9% |
| 2023 | 56 | +273.3% |
| 2024 | 36 | -35.7% |
Botswana compared with similar countries
- Botswana's 36 is below the median for upper middle income countries, which is 41, 88% of the median. (57 countries reporting)
- Botswana's 36 is below the median for Sub-Saharan Africa, which is 152.5, 24% of the median. (48 countries reporting)
Biggest year-on-year movements
Years where Confirmed cases of RR-/MDR-TB in Botswana changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2023 | +273.3% | 15 | 56 |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 134.67 | 126 | 139 | 3 |
| 2010s | 74.2 | 41 | 122 | 10 |
| 2020s | 43 | 15 | 65 | 4 |
Countries ranked near Botswana
- 99 Italy 38 compare
- 100 Mauritania 37 compare
- 102 Equatorial Guinea 35 compare
- 103 Gambia 32 compare
- 104 Canada 30 compare
- 104 Saudi Arabia 30 compare
More health data for Botswana
- Un projection of annual infant deaths, annual growth rate -1.75 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2265 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,150 deaths per 1,000 people (2090)
- Number of infants who die before age 1 281 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.6484 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0579 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9109 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is confirmed cases of rr-/mdr-tb in Botswana?
- Confirmed cases of rr-/mdr-tb in Botswana was 36 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest confirmed cases of rr-/mdr-tb recorded in Botswana?
- The highest recorded value was 139 in 2007.
- What is the lowest confirmed cases of rr-/mdr-tb recorded in Botswana?
- The lowest recorded value was 15 in 2021.
- How does Botswana rank for confirmed cases of rr-/mdr-tb?
- Botswana ranks 101st out of 195 countries with data for 2024.
- Is confirmed cases of rr-/mdr-tb rising or falling in Botswana?
- Over the last ten years it is down 12.2%. The long-run trend across the full record is falling.
- Where does this Botswana data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Confirmed cases of RR-/MDR-TB. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).